Oliver Malard

Centre Hospitalier Universitaire de Nantes

Papers

1

Total Citations

79

H-Index

1

About

Dr. Oliver Malard is a leading French otolaryngologist and head and neck surgeon whose research focuses on minimally invasive surgical approaches for laryngopharyngeal cancers, particularly supraglottic squamous cell carcinoma. As a key member of the GETTEC (Groupe d'Étude des Tumeurs de la Tête et du Cou) evaluation cooperative subgroup, Dr. Malard has made significant contributions to advancing transoral robotic surgery (TORS) as an organ-preserving alternative to traditional chemoradiotherapy. His landmark 2015 study, cited 79 times, demonstrated that TORS offers comparable oncologic outcomes with reduced toxicity, establishing a paradigm shift in treatment protocols. This work has been instrumental in validating robotic surgery as a safe, effective option that spares patients the debilitating side effects of combined chemoradiation while maintaining excellent functional results. Dr. Malard's research bridges the critical gap between surgical innovation and clinical application, providing robust evidence that minimally invasive techniques can achieve superior quality of life without compromising survival rates. His contributions continue to shape European guidelines for head and neck cancer management, making him a pivotal figure in the evolution of organ-preservation strategies.

Research Focus

Key Achievements

1
H-Index
1
Papers
79
Total Citations
79
Avg Citations/Paper
🏆 Most Cited Paper
Clinical outcomes with transoral robotic surgery for supraglottic squamous cell carcinoma: Experience of a French evaluation cooperative subgroup of GETTEC
79 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Centre Hospitalier Universitaire de Nantes

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago